Bridget Keenan, MD, PhD, of UCSF, stresses close communication across clinical, industry, and lab teams to run safe CAR T-cell trials.
Bridget Keenan, MD, PhD
Advertisement
Bridget Keenan, MD, PhD, is an assistant professor at UCSF who coleads the institution's Cancer Immunotherapy Research and Clinical Translation Unit.
Articles by Bridget Keenan, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
CMS Final Rule Ends Federal Medicaid, CHIP Funding for Youth Gender-Affirming Care
2
Trump Childhood Vaccine Order: What It Means for Parents and Payers
3
Employers With Claims Data Access Take More Cost Action, Survey Finds
4
CAR T, Bispecifics Reshape Relapsed Lymphoma Care: Madhav Seshadri, MD
5